glp-1 and Weight Loss Options Decoding GLP-1 Weight Loss Medications

Worth noting Contains a retinoid, which is best introduced gradually

The SELECT trial reported a 20% reduction in major adverse cardiovascular events with semaglutide versus placebo in patients with overweight/obesity and established cardiovascular disease, without diabetes [34] [35]

AhrnBSimonssonELarssonHLandin-OlssonMTorgeirssonHJanssonPAet al

Providing access to proven GLP-1 medications could benefit health outcomes for a wide group of Americans and reduce the strain on the healthcare system associated with treating diabetes and related conditions

Prince provides guidance on maintaining the benefits and suggests an appropriate maintenance schedule based on individual needs